2 Dividend Stocks Defying the Market Dip to Buy for a Lifetime of Passive Income [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
Still, some companies are doing just fine amid the volatility, including AbbVie (NYSE: ABBV) and Abbott Laboratories (NYSE: ABT) . These two healthcare leaders may or may not continue beating the market in the next few weeks -- it's challenging to predict the direction of any single stock or the broader equities in such a short period. However, no matter what happens in the near term, AbbVie and Abbott Laboratories are excellent long-term picks for dividend-focused investors. Here's why. AbbVie's shares dropped off a cliff in November after it announced a clinical setback for emraclidine, an investigational schizophrenia treatment it got in an $8.7 billion acquisition. Investors were worried the company spent nearly $9 billion for nothing, which is understandable. However, AbbVie's shares have been on a tear since that dip, and it has maintained that momentum through 2025, at least so far. Though the emraclidine setback was concerning news, AbbVie still has excellent prospects t
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Gastrointestinal Diagnostics Industry Worth $5.8 Billion by 2030: Analysis of Global Markets and Major Companies [Yahoo! Finance]Yahoo! Finance
- Abbott Integrates Libre's Data with Epic's Electronic Health Record System, Providing Healthcare Professionals Seamless Glucose Monitoring Information [Yahoo! Finance]Yahoo! Finance
- Abbott Integrates Libre's Data with Epic's Electronic Health Record System, Providing Healthcare Professionals Seamless Glucose Monitoring InformationPR Newswire
- Persivia Completes $107M Recapitalization to Drive Next Phase of Growth [Yahoo! Finance]Yahoo! Finance
- 3 Dividend Stocks to Buy and Hold for the Next Decade [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 4/16/25 - Beat
ABT
Sec Filings
- 4/30/25 - Form 144
- 4/30/25 - Form 10-Q
- 4/29/25 - Form 4
- ABT's page on the SEC website